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ABSTRACT
Natural products from the unique environments of sea water and oceans represent a
largely unfamiliar source for isolation of new microbes, which are potent producers
of secondary bioactive metabolites. These unique life-forms from the marine
ecosphere have served as an important source of drugs since ancient times and still
offer a valuable resource for novel findings by providing remedial treatments.
Therefore, it can be expected that many naturally bioactive marine microbial
compounds with novel structures and bioactivities against those from terrestrial
environments may be found among marine metabolites. Biofilms in aquatic
environment possess serious problems to naval forces and oceanic industries around
the globe. Current anti-biofilm or anti-biofouling technology is based on the use of
toxic substances that can be harmful to their surrounding natural locales.
Comprehensive research has been done to examine the bioactive potential of marine
microbes. Results are remarkably varied and dynamic, but there is an urgent need for
bioactive compounds with environmentally friendly or “green” chemical activities.
Marine microbes have the potential as upcoming and promising source of non-toxic
compounds with sustainable anti-biofouling/anti-biofilm properties as they can
produce substances that can inhibit not only the chemical components required for
biofilm production but also the attachment, microorganism growth, and/or cell–cell
communication.
Subjects Ecology, Marine Biology, Microbiology, Ecotoxicology, Green Chemistry
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INTRODUCTION
Little is known about the ecology of marine microorganisms, which is probably the reason
that attention was not given by chemists and ecologists to these organisms for many years.
As they flourish in diverse types of ecological pressures, climates, food supplies, and
darkness, these marine organisms develop certain adaptation mechanisms. This can
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include the struggle for space, avoidance of predators, ability to effectively reproduce,
and many other unknown defense mechanisms. Evolution/production of unique and
natural bioactive metabolites is one such outcome resulting from these adaptations,
which can be beneficial for human beings in many ways. They can possibly be responsible
for the interaction with chemical components of biofilms (Joint, Muhling &
Querellou, 2010).
Naturally bioactive chemical compounds produced by bacteria and diatoms can cause
disruption in biofilm formation (Ganapiriya, Maharajan & Kumarasamy, 2012);
therefore, they can be useful in development of environmentally friendly compounds for
protection against marine bio-fouling (Holmstro¨m & Kjelleberg, 1999). It is just a matter of
finding the correct naturally bioactive compound for a specific application. Coating and
application of active ingredients from marine organisms (invertebrates, microorganisms,
algae) that prevent the growth and settlement of fouling organisms has been proposed
since the 1980s (Maki et al., 1988) but none of the potent, non-toxic, naturally bioactive
compounds from diverse marine life-forms are found to be active against biofouling.
When compared with the natural anti-biofoulants from macro-organisms (sponges,
mollusks, tunicates, bryozoans, polychetes, and many other marine invertebrates), very
limited information is available from marine microorganisms (Fusetani, 2004).
Our aim through this literature review was to search for potential biologically active
compounds, whose chemical information can be useful in facilitating the development of
new anti-biofouling or anti-biofilm agents from natural marine sources (Li et al., 2018).
These agents should possess some extent of bioactivity, either against biofilms or any other
biofilm producing microorganism and must rely on two actions: (1) synergistic action
and (2) continuous production of enough potent molecules/defensive compounds by
microbes so that they may also be induced upon attacks on the host. Thus far, after
comparing the available information on bioactive metabolites from macro-organisms,
only a small number of microorganisms have been investigated for bioactive metabolites
(Debbab et al., 2010). This review covers future research with new biologically active
natural marine microbial compounds and highlights their mechanism of action with
focus on chemical potential. Meticulous research in the field of bioactive compounds
from marine microbes may open the gates for many prospect implications in oceanic
industries as well as in the field of biomedical sciences.
The ocean is called the “mother of origin of life,” and an enormous proportion of all life
on Earth exists within the oceans (Mora et al., 2011). In densely populated marine
environments, space is often a limiting factor. When free space is not available, one
organism grows on top of another one. This process is defined as epibiosis (Wahl et al.,
2012). Adaptation to epibiosis arises via three methods: (1) tolerance; (2) avoidance; and
(3) defense (Wahl et al., 2012). Overgrowth is controlled by employing either one or a
combination of ecological, physical, and chemical defense mechanisms (Wahl, Jensen &
Fenical, 1994), which includes the major factor, production of bioactive metabolites
(Wahl & Banaigs, 1991). Studies unraveling the epibiotic chemical defense of marine
microorganisms can provide insight into the development of novel ecofriendly antifouling
compounds and strategies (Jensen & Fenical, 1996).
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Biofouling occurrence in the marine environment is a sequential process, commencing
with micro-fouling and concluding with macro-fouling. The adverse effects of biofouling
and economic penalties to the marine industries are well known (Bekiari et al., 2015;
Dang & Lovell, 2016). In addition, fouling is also known to cause destruction of metallic
surfaces by accelerating the corrosion rate (Edyvean, Thomas & Brook, 1988). Numerous
efforts are beingmade to control biofouling with applications of physical, chemical, biological
compounds, but it is achieved to the greatest extent only with the use of anti-fouling paint
coatings (Cao et al., 2011; Iorhemen, Hamza & Tay, 2016; Lade, Paul & Kweon, 2014).
Use of toxic anti-foulants and its related environmental concerns have caused an increase
in development of non-toxic alternatives (Callow & Callow, 2011; Nurioglu, Esteves &
de With, 2015). In this perspective, studies concerning marine micro-organisms’ epibiotic
chemical defense in the control of biofouling show great promise. Efforts in these areas have
proven that the wide range of marine organisms such as algae, sponges, gorgonians,
bryozoans, and ascidians are a potential source of anti-fouling metabolites (Ganapiriya,
Maharajan & Kumarasamy, 2012; Zhang et al., 2014). However, not much detail is known to
date regarding anti-biofouling/anti-biofilm natural compounds from marine
microorganisms. Figure 1 demonstrates statistics about the number of publications in
PubMed from 1989 until 2017 regarding this subject. These data explain the urgent need to
explore the enigma of favorable marine microbes’ activities against biofouling. Since the
beginning of this type of research, studies concerning marine microbial metabolites, have
Figure 1 Comparative statistical data about number of publications in PubMed since 1989 till 2017.
Comparative general data about the number of publications in PubMed when searching for several
keywords/phrases: (1) microbial natural bioactive compounds (blue column); (2) marine microbial
natural bioactive compounds (yellow column); (3) microbial anti-biofilm compounds (red column);
and (4) marine microbial anti-biofilm compounds (green column). Moving average trend lines show
the importance and urgent need for research concerning on marine microbial natural anti-biofouling/
anti-biofilm compounds. Full-size DOI: 10.7717/peerj.5049/fig-1
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shown significance that is only related to therapeutic and pharmaceutical agents for various
commercial and medical applications (Table 1); however, none have been identified to date,
which can be viewed as the existence of potent anti-biofouling/anti-biofilm marine
microbial derivatives without any synthetic modifications.
Enormous numbers of studies have been done to discover natural product-derived
anti-foulants as a substitute for toxic anti-fouling paints (Ciriminna, Bright & Pagliaro,
2015; Omae, 2003; Qian, Xu & Fusetani, 2009; Wang et al., 2017). Epibiotic chemical
defense of marine organisms have been evaluated, but some restrictions hindered those
investigations. For instance, these studies were carried out in the laboratory against one or
two groups of epibionts (Davis, 1991; Laudien & Wahl, 2004), and such unrealistic assay
conditions do not exist in nature (Henrikson & Pawlik, 1998). This restricts the scope of
studies concerning epibiotic chemical defense in marine organisms, which present a wide
range of epibionts in nature. In this respect, evaluation of metabolites obtained from
marine microorganisms against broad spectrum of epibionts provides better insight into
epibiotic chemical defense (Penesyan, Kjelleberg & Egan, 2010).
In the real world, identification of bioactive metabolites origins is complicated as some
marine invertebrates are home for a wide range of bacteria. For example, in some sponge
species, bacteria contribute up to 60% of the total biomass (Mohamed et al., 2008) and in
Table 1 List of areas commonly known for applications/uses of marine microbial natural bioactive
compounds.
Medical significance of marine microbial metabolites
Antibacterial
Antiviral
Antiparasitic
Antifungal
Anticoagulant
Antimutagenic
Antihyperglycaemic
Antitumoral
Antiinflammatory
Anticarcinogenic
Antioxidant
Taste astringent
Photoprotection
Immunomodulator
Emulsifier
Gelling agent
Cosmetics industry
Textile industry
Stimulant
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some studies they have been reported to produce bioactive metabolites similar to their
host (Grac¸a et al., 2015; Elyakov et al., 1991). Such cases are a subject of scientific debate.
Several other studies have reported the isolation of bioactive metabolites from
microorganisms associated with their invertebrate hosts (Kelecom, 2002; Bernan,
Greenstein & Maiese, 1997; Hay, 2009). As an example, the marine sponge was the known
source for the isolation of surfactant-like depsipeptides (Prasad et al., 2011; Anjum et al.,
2016). Later, it was found that the bacterium Bacillus pumilus produces these compounds
which were previously associated with just the sponge (Kalinovskaya et al., 1995).
In view of this, it is important to understand the role of associated bacteria in the
production of bioactive metabolites and the importance of their association with
the invertebrate host, which is still not clear at this time. However, studies to explore the
relationship between anti-microbial activity and anti-fouling activities are lacking. In this
context, studies to elucidate the effectiveness/isolation of various types of extracts against/
frommicroorganisms will give a better understanding of these microorganisms’ activities.
SURVEY METHODOLOGY
All peer reviewed scientific papers were used for this review article. Extensive literature
searches have been performed using various literature search engines, including Science
Direct and PubMed with several terms: (1) microbial natural bioactive compounds;
(2) marine microbial natural bioactive compounds; (3) microbial anti-biofilm compounds;
and (4) marine microbial anti-biofilm compounds. All relevant studies meeting search
criteria were included in this review.
Need for antibiofilm or antibiofouling bioactive compounds with
green chemistry
What is green chemistry and why do we need it? Chemistry is undeniably a very obvious
part of our daily lives, and new chemical developments bring new environmental
complications with unexpected harmful side effects. Hence, there is continued pressure on
various chemical industries to reduce chemical waste and use their creativity to develop
novel synthetic methods, reaction conditions, analytical tools, catalysts, and processes
under the new paradigm of “green chemistry” (Erickson, Nelson & Winters, 2012).
The term green chemistry, also known as sustainable chemistry, was introduced by Paul
Anastas in 1991 (Matthews, 2000). Twelve principles of green chemistry were created that
encompass a new attitude toward industrial practices and chemical syntheses (Winterton,
2016). This set of principles describes guidelines for reduction/elimination of the
generation of hazardous substances while designing, manufacturing, and applying any
chemical products. It is the only science that focuses on the intrinsic hazards of a chemical
or chemical process. Thus, to realize more sustainable thinking and implementation of
sustainability criteria in research, development, and production, educational strategies
have to include green chemistry principles and indicators of sustainability (Burmeister,
Rauch & Eilks, 2012; Wilson & Schwarzman, 2009).
Formation of biofilms leads to biofouling, which is a process of gradual accumulation
of waterborne organisms on natural and artificial surfaces of marine environment that
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leads to corrosion and decline in the efficiency of moving parts (Adnan et al., 2010; Adnan,
Morton & Hadi, 2011; Yebra, Kiil & Dam-Johansen, 2004). Advances in polymer chemistry
in the early 1970s led to biofouling control, but it was based on the use of toxic substances
such as tributyl tin (TBT) (Rouhi, 1998), copper or organic compounds (such as Sea-Nine,
isothiazolone) (Yebra, Kiil & Dam-Johansen, 2004), or self-polishing copolymer anti-
fouling paints, in which organotins are the biocides. So far, organotins are the most
effective methods of biofouling control; however, these chemicals are toxic to aquatic
environments (Yebra, Kiil & Dam-Johansen, 2004). The use of such toxic biocides presents
environmental concerns involving anomalies in non-target organisms that include shell
malformation in bivalves, depletion of oyster population, imposex in gastropods, and
others (Park et al., 2016). TBT has been labeled as the most lethal substance to have been
deliberately introduced in to the marine environment by man (Park et al., 2016). In
general, the use of such toxins in marine environments poses a real threat to the marine
biota (Fleming et al., 2006). Effective from January 2008, the International Maritime
Organization (IMO) and Marine Environmental Protection Committee (MEPC)
introduced resolutions to ban the practice of using TBTor other substances containing tin
as biocides (Champ, 2003). Therefore, there is a need for the development of
environmental friendly non-toxic and natural anti-biofouling agents.
Advancement in methods used to prevent microbial biofilm and
biofouling
Since removal of biofilms is a very difficult, challenging, and demanding process, a
complete and cost-effective cleaning procedure should be developed (Caixeta et al., 2012)
because an inappropriate cleaning strategy generally leads to biofilm formation (Garrett,
Bhakoo & Zhang, 2008). A number of methods can be used to prevent microbial biofilm
formation and/or biofouling. Currently, these measures fall into three economically
lucrative categories: (1) physical; (2) chemical; and (3) biological methods (Cao et al.,
2011). In this review, we will discuss the biological methods that are currently used.
Adsorption of bioactive compounds such as bacteriocins and nisin onto food-contact
surfaces reduces bacterial adhesion. Enzyme mixtures have also proven to be effective for
cleaning and biofilm removal (Garrett, Bhakoo & Zhang, 2008; Stiefel et al., 2016; Guerra
et al., 2005; Van Houdt & Michiels, 2010; Pimentel-Filho et al., 2014). Unique properties of
Endo H (endoglycosidases) for removal of bacteria such as Staphylococci and E. coli
from glass and cloth surfaces makes it useful in buffers and detergent solutions
(Carpenter, Goldstein & Lad, 1995). Colanic acid-degrading enzymes, derived from a
Streptomyces isolate, are also useful for removal and prevention of biofilm formation
(Van, Bruggeman & Van, 1996).
Marine benthic organism surfaces act as potential locations for the settlement of
fouling organisms, including bacteria, algae, and invertebrates (Cao et al., 2011; Pereira
et al., 2002). However, at the same time these organisms present a great variety of potential
defense mechanisms against fouling organisms, which include surface sloughing,
possession of spines, production of mucus, low surface energy, and secondary metabolite
production (Pereira et al., 2002). Secondary metabolites demonstrating anti-fouling
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properties opened a new perception into inhibition of overgrowth by epibionts and could
possibly be used as commercial anti-biofoulants (Wahl et al., 2012). In fact, a vast range of
tested anti-biofoulants have been patented. However, these anti-biofoulants have been
tested under laboratory conditions, using the larvae of fouling organisms such as
barnacles and bryozoans (Pereira et al., 2002; Zimmerman et al., 1997). Moreover, there
are only few studies in which this test has been performed under ecological settings, in
which real concentrations of metabolites found in source organisms were used (Da Gama
et al., 2002). From a molecular perspective, secondary marine metabolites seem to hinder
bacterial colonization and can control biofilm formation/biofouling (Kjelleberg et al.,
1997). To justify and prove this statement, further investigations, including ecological and
molecular tests, are required.
Ecological role of marine bioactive compounds
Natural marine products, secondary metabolites, enzymes, lipids, and
heteropolysaccharides derived from marine sources are biologically active. Moreover, they
are safer, cheaper, and less toxic than existing medicines (D’Ayala, Malinconico &
Laurienzo, 2008; Berge´ & Barnathan, 2015). Out of 36 known living phyla, 34 are found in
throughout the marine environment with more than 300,000+ known species of flora and
fauna (Baskaran et al., 2017) (and still counting). However, the detailed ecological role of
these marine animal-extracted secondary metabolites, which includes prevention of
fouling, anti-predation, protection from ultraviolet radiation, mediation of spatial
competition, and other functions (Armstrong, Boyd & Burgess, 2000) is still not clear and
present areas for novel and extensive studies.
Many natural marine products are currently being tested in clinical trials, and various
others are presently used for treating microbial infections (fungal, malarial, bacterial,
viral, and nematode) and pain management in addition to cancer and inflammation
control (Martins et al., 2014). The first marine compound to enter a human cancer clinical
trial as a purified natural product was Didemnin-B from the Caribbean tunicate
Trididemnum solidum (Ram et al., 2008). Unfortunately, secondary metabolites of macro-
organisms are usually present in trace amounts, and that presents a drawback to use of the
marine compounds. Due to less stock, the marine compound cannot compete with the
development of widely available medicines. The developmental ways such as bioprocess
engineering is currently the most important method for obtaining large quantities of
beneficial secondary metabolites. This can only be accomplished by extracting and testing
less investigated drug sources such as marine fungi and bacteria, which are vast untapped
reservoirs of metabolic diversity (Debbab et al., 2010).
Microorganisms have some advantages such as isolation of the same compound in
large-scale cultivation using biotechnological fermentations and advance bioprocessing
engineering techniques with different parameters without ecological exploitation. They
can also easily be genetically manipulated. There is still opportunity for an advanced scale
of research and investigation to discover the potential of marine microorganisms as
producers of novel drugs (Malve, 2016).
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Bioactive compounds from marine bacteria, fungi and cyanobacteria
Over the last several decades, microorganisms have been accepted as significant and
unexploited resources for many unique bioactive compounds with clinical significance
(Malve, 2016; Zhang et al., 2005). It is very clear that microbial diversity found in the
oceans is poorly understood, and <5% of marine bacterial and fungal species are known
(de Felı´cio et al., 2015). Microbes thrive not only in the sea’s surface waters but also in the
lower and immeasurable depths (Das, Lyla & Khan, 2006). For survival, soft-bodied
marine organisms rely on chemical defenses from the production of bioactive secondary
metabolites either by themselves or in association with microflora (Mehbub et al., 2014).
These secondary metabolites may represent a diverse structure of classes that include
terpenes, peptides, polypeptides, and compounds of mixed biosynthetic origin. A total of
961 new compounds from marine microorganisms were described in the year 2007 (Blunt
et al., 2009). These studies and the sharp rise in numbers of these compounds indicate that
the study on secondary metabolites from marine bacteria and fungi as source of new
bioactive metabolites has been steadily increasing. So far, only a few anti-larval settlement
compounds have been isolated and identified from bacteria (Table 2).
One of the ways of discovering novel bioactive metabolites from marine
microorganisms is via isolation of new microorganisms. Research over the years has
demonstrated that out of 10% of cultivable microorganisms, only 1% were found to have
clinical and industrial significance (Vartoukian, Palmer & Wade, 2010). Due to the
complex nature of the oceans, marine bacteria have developed sophisticated physiological
and biochemical systems with which they uniquely adapt to extreme habitats and various
unfavorable marine environmental conditions. They live in a biologically competitive
environment with unique conditions of pH, temperature, pressure, oxygen, light,
nutrients, and salinity, which is especially rich in chlorine and bromine elements.
Microbes can quickly sense, adapt, and respond to their environments (Adnan et al., 2010;
Adnan, Morton &Hadi, 2011) and can compete for defense and survival via the generation
of unique secondary metabolites. Although the response to stress initiates the production
of these compounds, they have shown value in pharmaceutical and biotechnological
applications (Darvishi Harzevili & Chen, 2014).
Among all microorganisms, fungi are found to be a potentially useful source of
pharmacologically active metabolites because they have the capability to adapt and survive
in marine environments and to produce unique secondary metabolites. Fungi have also
been widely distributed in marine habitats such as seawater, sediment, marine animals,
and plants. Even though decomposition of dead plants and animal tissues has been
suggested to play an important ecological role in recycling nutrients (Zhang et al., 2015),
the role of marine fungi is poorly understood. Marine fungi have been isolated from
different marine habitats for the investigation of natural products (Imhoff, 2016). They
found to form a mutual synergetic relationship with other marine organisms such as
algae, sponges, mollusks and corals, but this association and related functions are rarely
known (Ding et al., 2011). Culture-based technology is used for the isolation of various
fungi from marine habitats. Due to their uniqueness when compared with their terrestrial
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Table 2 List of few marine microbial species reported to produce bioactive metabolites with antibiofilm and antifouling activities (Abu Sayem
et al., 2011; Arai, Niikawa & Kobayashi, 2013; Busetti et al., 2015; Dos Santos et al., 2010; Estrela & Abraham, 2016; Fusetani, 2011;
Hong & Cho, 2013; Jiang et al., 2011; Salta et al., 2013; Satheesh, Ba-Akdah & Al-Sofyani, 2016; Scopel et al., 2014; Shao et al., 2015; Shao
et al., 2011; Yang et al., 2007).
Microorganism Bioactive compound Biological
activity
Effects against Relevance
Bioactive compounds isolated from marine bacteria
Bacillus licheniformis a-D-galactopyranosyl-(1/2)-
glycerol-phosphate
Antibiofilm Escherichia coli and Pseudomonas
fluorescens
Clinical
Alteromonas sp. Ubiquinone-8 Antifouling Larval settlement of barnacle Balanus
amphitrite
Environmental
Acinetobacter sp. 6-bromoindole-3-carboxaldehyde Antifouling Larval settlement of barnacle Balanus
amphitrite
Environmental
Pseudomonas sp. Pyolipic acid Antifouling Larval settlement under laboratory and
field experiment assays
Environmental
Pseudomonas sp. Phenazine-1-carboxylic acid Antifouling Larval settlement under laboratory and
field experiment assays
Environmental
Pseudomonas sp. 2-alkylquinol-4-ones Antifouling Larval settlement under laboratory and
field experiment assays
Environmental
Streptomyces praecox Diketopiperazines Antifouling Larval settlement under laboratory and
field experiment assays
Environmental
Streptomyces
violaceoruber
3-octa-1′,3′-dienyl-4-methylfuran-2
(5H)-one
Antifouling Zoospores of Ulva pertusa, the diatom
Navicula annexa, and the mussel
Mytilus edulis
Environmental
Streptomyces
violaceoruber
3-octa-1′-enyl-4-methylfuran-2(5H)-
one
Antifouling Zoospores of Ulva pertusa, the diatom
Navicula annexa, and the mussel
Mytilus edulis
Environmental
Vibrio sp. QY101 Exopolysaccharide A101 Antibiofilm Pseudomonas aeruginosa FRD1 Clinical
Bioactive compounds isolated from marine fungi
Letendraea
helminthicola
3-methyl-N-(2-phenylethyl)
butanamide
Antifouling Larval settlement of barnacle Balanus
amphitrite
Industrial/Environmental
Scopulariopsis sp. Dihydroquinolin-2(1H)-one Antifouling Larval settlement of barnacle Balanus
amphitrite
Industrial/Environmental
Letendraea
helminthicola
Cyclo (D-Pro-D-Phe) Antifouling Larval settlement of barnacle Balanus
amphitrite
Cochliobolus lunatus Resorcyclic acid lactones Antifouling Larval settlement of barnacle Balanus
amphitrite
Industrial/Environmental
Emericella variecolor Ophiobolin K Antibiofilm Mycobacterium bovis Clinical
Emericella variecolor 6-epi-ophiobolin K Antibiofilm Mycobacterium smegmatis Clinical
Emericella variecolor 6-epi-ophiobolin Antibiofilm Mycobacterium smegmatis Clinical
Unidentified marine
fungus
Mevalonolactone Antibiofilm Staphylococcus epidermidis Clinical
Marine Penicillium sp. Cyclo(L-Tyr-L-Leu) Antibiofilm Staphylococcus epidermidis Clinical/Environmental
Penicillium commune Cyclo(L-Leu-L-Pro) Antibiofilm Staphylococcus aureus Clinical/Environmental
Cladosporium sp. F14 cyclo-(Phe-Pro) Antibiofilm Loktanella hongkongenis, Micrococcus
luteus and Ruegeria sp.
Clinical/Environmental
Cladosporium sp. cyclo-(Val-Pro) 4 Antibiofilm Loktanella hongkongenis Clinical/Environmental
Aspergillus flavipes Flavipesin A 49 Antibiofilm Staphylococcus aureus and Bacillus
subtilis
Clinical
(Continued)
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counterparts, they have also shown to be phylogenetically distant (Reich & Labes, 2017;
Re´dou et al., 2015). They are a promising source for new bioactive natural products with
high structural diversity when compared with other microbial sources isolated from the
sea. Because of their living conditions, including tolerance to salinity, high pressure,
nutrition requirements, temperature variations, and competition with other microbes, they
may have developed unique metabolic pathways (Samuel, Prince & Prabakaran, 2011).
The most famous and first reported group of bioactive compounds obtained from
marine-derived fungi were cephalosporins (with cephalosporin C) that were isolated by
Brotzu in 1945 from a marine strain of Acremonium chrysogenum. They had been
discovered in a sewage outlet in the Mediterranean Sea close to the island of Sardinia
coast, and they exhibited pronounced antibacterial activities (Silber et al., 2016; Demain &
Elander, 1999). After the discovery of cephalosporin C, siccayne was isolated from
Halocyphina vilosa and was identified as the second antibiotic from marine-derived fungi
(Kupka et al., 1981). Marine-derived fungi have been widely studied for novel anti-cancer,
anti-bacterial, anti-plasmodial, anti-inflammatory, and anti-viral agents (Rajasekar et al.,
2012). However, very few anti-biofilm/anti-biofouling bioactive metabolites have been
derived from marine fungi.
More than 270 new natural products isolated from marine fungi between 1990 and
2002 followed by 330 new metabolites between 2002 and 2006 have been reported (Imhoff,
2016). In 2009 and 2010, >472 new structures were reported. The total number of new
natural products from marine-derived fungi currently exceeds 1,000, and a few of them
are in preclinical and clinical trials (Gomes et al., 2015). The ecological role of these
multiple compounds include prevention of fouling, competition for space/resources,
protection from ultraviolet radiation, and facilitation of reproduction (Nunez-Pons &
Avila, 2015). These marine-derived fungal metabolites have been proven to be promising
anti-fouling/anti-biofilm agents, but still required additional investigation and
implementation in oceanic-related industries.
Marine cyanobacteria (blue–green algae) are another such group of prokaryotic
photosynthetic organism and are potent sources of pharmacological and industrial
products having diverse structures and habitats that are known to produce various
Table 2 (continued).
Microorganism Bioactive compound Biological
activity
Effects against Relevance
Bioactive compounds isolated from marine algae
Chondrus crispus (+)—Usnic acid Antibiofilm Cobetia marina and Marinobacter
hydrocarbonoclasticus
Environmental
Chondrus crispus Juglone Antibiofilm Cobetia marina and Marinobacter
hydrocarbonoclasticus
Environmental
Laurencia elata Elatol Antifouling Leishmania amazonensis Clinical
Halidrys siliquosa Organic extract Antibiofilm Staphylococcus; Streptococcus;
Enterococcus; Pseudomonas;
Stenotrophomonas; and
Chromobacterium
Clinical
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bioactive compounds (Mourelle, Go´mez & Legido, 2017). The potential use of
cyanobacteria has gained worldwide attention in view of their importance in agriculture,
industry, pharmaceutical markets, and other areas (Singh et al., 2017). They are the richest
sources of known and unique bioactive compounds, including toxins with potential for
therapeutic applications (Singh et al., 2017). Marine cyanobacteria demonstrate a wide
range of biological activities, including its use as biocontrol agents against various
bacterial and fungal pathogens in addition to its use as a potential source of novel
antibiotics. They are known to produce anti-bacterial and anti-fungal compounds
(Shantanu et al., 2013), anti-cancerous and anti-neoplastic agents, and compounds that
may be useful in the treatment of human immunodeficiency virus (Vijayakumar &
Menakha, 2015; Swain, Padhy & Singh, 2015). Screening of cyanobacteria for potent anti-
biofouling/anti-biofilm natural agents will open a new horizon for marine industries
(Table 2). More than 50% of marine cyanobacteria are potentially exploitable for
extracting bioactive substances, which can be effective anti-biofouling agents.
Cyanobacterial blooms are rich sources of secondary metabolites with novel chemical and
molecular structures (Engene et al., 2011). Exploring the efficiency of cyanobacterial
products has an advantage; it can be grown in mass culture, which can be manipulated to
attain optimal production of bioactive substances.
CONCLUSIONS
Ever since the beginning of development of a civilized society, biologically active
compounds, which are obtained from diverse range of microbes, have been extensively
investigated. Bacterial biofilms are the dominant reason for biofouling in most
commercial systems with no permanent solution toward removal of biofilms. Microbial
secondary bioactive metabolites possess quite a few pharmaceutical applications. Use of
ecofriendly biocides as an alternative to synthetic chemicals has recently emerged because
the sole purpose of green chemistry is to either discover or to produce the best and novel
chemical products that are safe for use with increased productivity. Unquestionably, our
understanding of the field of microbial metabolites has significantly improved over the
past several years, but there are still many steps to achieve a better understanding about
the potential of marine microbial metabolites. We are in a promising era of science, which
proves to be the right time; we can uncover the potential of marine microbes in the field of
biofouling prevention and not in biofouling causation. In order to explore the natural
anti-fouling/anti-biofilm compounds (green chemistry) and potential of marine
microbes, this review will definitely draw attention to the search for bioactive metabolites
that can resolve many difficulties and obstacles not only for oceanic industries, but many
other industrial systems.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
The authors received no funding for this work.
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 11/18
Competing Interests
The authors declare that they have no competing interests.
Author Contributions
 Mohd Adnan conceived and designed the experiments, analyzed the data, prepared
figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.
 Eyad Alshammari analyzed the data, authored or reviewed drafts of the paper, approved
the final draft.
 Mitesh Patel performed the experiments, contributed reagents/materials/analysis tools,
prepared figures and/or tables.
 Syed Amir Ashraf contributed reagents/materials/analysis tools, prepared figures and/or
tables.
 Saif Khan performed the experiments, analyzed the data, approved the final draft.
 Sibte Hadi conceived and designed the experiments, analyzed the data, authored or
reviewed drafts of the paper, approved the final draft.
Data Availability
The following information was supplied regarding data availability:
This is a review article that examined peer reviewed articles available in Science Direct
and Pubmed.
REFERENCES
Abu Sayem AM, Manzo E, Ciavatta L, Tramice A, Cordone A, Zanfardino A, De Felice M,
Varcamonti M. 2011. Anti-biofilm activity of an exopolysaccharide from a sponge-associated
strain of Bacillus licheniformis.Microbial Cell Factories 10(1):74 DOI 10.1186/1475-2859-10-74.
Adnan M, Morton G, Hadi S. 2011. Analysis of rpoS and bolA gene expression under various
stress-induced environments in planktonic and biofilm phase using 2–CTmethod.Molecular
and Cellular Biochemistry 357(1–2):275–282 DOI 10.1007/s11010-011-0898-y.
Adnan M, Morton G, Singh J, Hadi S. 2010. Contribution of rpoS and bolA genes in
biofilm formation in Escherichia coli K-12 MG1655. Molecular and Cellular Biochemistry
342(1–2):207–213 DOI 10.1007/s11010-010-0485-7.
Anjum K, Abbas SQ, Shah SAA, Akhter N, Batool S, ul Hassan SS. 2016. Marine sponges as a
drug treasure. Biomolecules & Therapeutics 24(4):347–362 DOI 10.4062/biomolther.2016.067.
Arai M, Niikawa H, Kobayashi M. 2013. Marine-derived fungal sesterterpenes, ophiobolins,
inhibit biofilm formation of Mycobacterium species. Journal of Natural Medicines
67(2):271–275 DOI 10.1007/s11418-012-0676-5.
ArmstrongE,BoydKG,Burgess JG. 2000.Preventionofmarine biofoulingusing natural compounds
from marine organisms. Biotechnology Annual Review. Vol. 6. Sixth Edition. Elsevier, 221–241.
Baskaran R, Subramanian T, Zuo W, Qian J, Wu G, Kumar A. 2017. Major source of marine
Actinobacteria and its biomedical application. In: Kalia VC, ed. Microbial Applications Vol.2:
Biomedicine, Agriculture and Industry. Cham: Springer International Publishing, 55–82.
Bekiari V, Nikolaou K, Koromilas N, Lainioti G, Avramidis P, Hotos G, Kallitsis JK, Bokias G.
2015. Release of polymeric biocides from synthetic matrices for marine biofouling applications.
Agriculture and Agricultural Science Procedia 4:445–450 DOI 10.1016/j.aaspro.2015.03.051.
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 12/18
Berge´ JP, Barnathan G. 2015. Fatty acids from lipids of marine organisms: molecular biodiversity,
roles as biomarkers, biologically active compounds, and economical aspects. In: Ulber R, Le
Gal Y, eds. Marine Biotechnology I. Berlin, Heidelberg: Springer Berlin Heidelberg, 49–125.
Bernan VS, Greenstein M, Maiese WM. 1997.Marine microorganisms as a source of new natural
products. In: Neidleman SL, Laskin AI, eds. Advances in Applied Microbiology. Vol. 43.
Cambridge: Academic Press, 57–90.
Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, Prinsep MR. 2009. Marine natural
products. Natural Product Reports 26:170–244.
Burmeister M, Rauch F, Eilks I. 2012. Education for sustainable development (ESD) and
chemistry education. Chemistry Education Research and Practice 13:59–68.
Busetti A, Thompson PT, Tegazzini D, Megaw J, Maggs CA, Gilmore BF. 2015. Antibiofilm
activity of the brown algaHalidrys siliquosa against clinically relevant human pathogens.Marine
Drugs 13(6):3581–3605 DOI 10.3390/md13063581.
Caixeta DS, Scarpa TH, Brugnera DF, Friere DO, Alves E, De Abreu LR, Piccoli RH. 2012.
Chemical sanitizers to control biofilms formed by two Pseudomonas species on stainless steel
surface. Food Science and Technology 32(1):142–150 DOI 10.1590/s0101-20612012005000008.
Callow JA, Callow ME. 2011. Trends in the development of environmentally friendly fouling-
resistant marine coatings. Nature Communications 2(1):244 DOI 10.1038/ncomms1251.
Cao S, Wang J, Chen H, Chen D. 2011. Progress of marine biofouling and antifouling
technologies. Chinese Science Bulletin 56(7):598–612 DOI 10.1007/s11434-010-4158-4.
Carpenter RS, Goldstein IJ, Lad PJ. 1995. Cleaning composition containing a type II
endoglycosidase. Google Patents .
Champ MA. 2003. Economic and environmental impacts on ports and harbors from the
convention to ban harmful marine anti-fouling systems. Marine Pollution Bulletin
46(8):935–940 DOI 10.1016/s0025-326x(03)00106-1.
Ciriminna R, Bright FV, Pagliaro M. 2015. Ecofriendly antifouling marine coatings. ACS
Sustainable Chemistry & Engineering 3(4):559–565 DOI 10.1021/sc500845n.
Da Gama BAP, Pereira RC, Carvalho AGV, Coutinho R, Valentin Y. 2002. The effects of seaweed
secondary metabolites on biofouling. Biofouling 18(1):13–20
DOI 10.1080/08927010290017680.
Dang H, Lovell CR. 2016. Microbial surface colonization and biofilm development in marine
environments. Microbiology and Molecular Biology Reviews 80:91–138
DOI 10.1128/mmbr.00037-15.
Darvishi Harzevili F, Chen H. 2014. Microbial Biotechnology: Progress and Trends. Boca Raton:
CRC Press.
Das S, Lyla PS, Khan SA. 2006. Marine microbial diversity and ecology: importance and future
perspectives. Current Science 90(10):1325–1335.
Davis AR. 1991. Alkaloids and ascidian chemical defense: evidence for the ecological role of
natural products from Eudistoma olivaceum. Marine Biology 111(3):375–379
DOI 10.1007/bf01319409.
D’Ayala GG, Malinconico M, Laurienzo P. 2008. Marine derived polysaccharides for biomedical
applications: chemical modification approaches. Molecules 13(9):2069–2106
DOI 10.3390/molecules13092069.
de Felı´cio R, Pava˜o GB, de Oliveira ALL, Erbert C, Conti R, Pupo MT, Furtado NA, Ferreira EG,
Costa-Lotufo LV, Young MCM, Yokoya NS. 2015. Antibacterial, antifungal and cytotoxic
activities exhibited by endophytic fungi from the Brazilian marine red alga Bostrychia tenella
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 13/18
(Ceramiales). Revista Brasileira de Farmacognosia 25(6):641–650
DOI 10.1016/j.bjp.2015.08.003.
Debbab A, Aly AH, Lin WH, Proksch P. 2010. Bioactive compounds from marine bacteria and
fungi. Microbial Biotechnology 3(5):544–563 DOI 10.1111/j.1751-7915.2010.00179.x.
Demain AL, Elander RP. 1999. The beta-lactam antibiotics: past, present, and future. Antonie van
Leeuwenhoek 75:5–19.
Ding B, Yin Y, Zhang F, Li Z. 2011. Recovery and phylogenetic diversity of culturable fungi
associated with marine sponges Clathrina luteoculcitella and Holoxea sp. in the South China
Sea. Marine Biotechnology 13:713–721 DOI 10.1007/s10126-010-9333-8.
Dos Santos AO, Veiga-Santos P, Ueda-Nakamura T, Filho BP, Sudatti DB, Bianco EM,
Pereira RC, Nakamura CV. 2010. Effect of elatol, isolated from red seaweed Laurencia dendroidea,
on Leishmania amazonensis. Marine Drugs 8(11):2733–2743 DOI 10.3390/md8112733.
Edyvean RGJ, Thomas CJ, Brook R. 1988. The effect of marine fouling on fatigue and corrosion-
fatigue of offshore structures. In: Houghton DR, Smith RN, Eggins HOW, eds. Biodeterioration 7.
Dordrecht: Springer Netherlands, 385–390.
Elyakov GB, Kuznetsova T, Mikhailov VV, Maltsev II, Voinov VG, Fedoreyev SA. 1991.
Brominated diphenyl ethers from a marine bacterium associated with the spongeDysidea sp.
Experientia 47(6):632–633 DOI 10.1007/bf01949894.
Engene N, Choi H, Esquenazi E, Rottacker EC, Ellisman MH, Dorrestein PC, Gerwick WH.
2011. Underestimated biodiversity as a major explanation for the perceived rich secondary
metabolite capacity of the cyanobacterial genus Lyngbya. Environmental Microbiology
13(6):1601–1610 DOI 10.1111/j.1462-2920.2011.02472.x.
Erickson B, Nelson JE, Winters P. 2012. Perspective on opportunities in industrial biotechnology
in renewable chemicals. Biotechnology Journal 7(2):176–185 DOI 10.1002/biot.201100069.
Estrela AB, Abraham WR. 2016. Fungal metabolites for the control of biofilm infections.
Agriculture 6(3):37 DOI 10.3390/agriculture6030037.
Fleming LE, Broad K, Clement A, Dewailly E, Elmir S, Knap A, Pomponi SA, Smith S, Solo
Gabriele H, Walsh P. 2006. Oceans and human health: emerging public health risks in the
marine environment. Marine Pollution Bulletin 53(10–12):545–560
DOI 10.1016/j.marpolbul.2006.08.012.
Fusetani N. 2004. Biofouling and antifouling. Natural Product Reports 21(1):94–104
DOI 10.1039/b302231p.
Fusetani N. 2011. Antifouling marine natural products. Natural Product Reports 28(2):400–410
DOI 10.1039/c0np00034e.
Ganapiriya V, Maharajan A, Kumarasamy P. 2012. Antifouling effect of bioactive compounds
from marine sponge Acanthella elongata and different species of bacterial film on larval
attachment of Balanus amphitrite (cirripedia, crustacea). Brazilian Archives of Biology and
Technology 55(3):395–402 DOI 10.1590/s1516-89132012000300010.
Garrett TR, Bhakoo M, Zhang Z. 2008. Bacterial adhesion and biofilms on surfaces. Progress in
Natural Science 18(9):1049–1056 DOI 10.1016/j.pnsc.2008.04.001.
Gomes NGM, Lefranc F, Kijjoa A, Kiss R. 2015. Can some marine-derived fungal
metabolites become actual anticancer agents? Marine Drugs 13(6):3950–3991
DOI 10.3390/md13063950.
Grac¸a AP, Viana F, Bondoso J, Correia MI, Gomes L, Humanes M, Reis A, Xavier JR, Gaspar H,
Lage OM. 2015. The antimicrobial activity of heterotrophic bacteria isolated from the marine
sponge Erylus deficiens (Astrophorida, Geodiidae). Frontiers in Microbiology 6:389
DOI 10.3389/fmicb.2015.00389.
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 14/18
Guerra NP, Araujo AB, Barrera Am, Agrasar AT, Macı´as CL, Carballo J, Pastrana L. 2005.
Antimicrobial activity of nisin adsorbed to surfaces commonly used in the food industry.
Journal of Food Protection 68(5):1012–1019 DOI 10.4315/0362-028x-68.5.1012.
Hay ME. 2009.Marine chemical ecology: chemical signals and cues structure marine populations,
communities, and ecosystems. Annual Review of Marine Science 1(1):193–212
DOI 10.1146/annurev.marine.010908.163708.
Henrikson AA, Pawlik JR. 1998. Seasonal variation in biofouling of gels containing extracts of
marine organisms. Biofouling 12(1–3):245–255 DOI 10.1080/08927019809378357.
Holmstro¨m C, Kjelleberg S. 1999. Marine Pseudoalteromonas species are associated with higher
organisms and produce biologically active extracellular agents. FEMS Microbiology Ecology
30(4):285–293 DOI 10.1111/j.1574-6941.1999.tb00656.x.
Hong YK, Cho JY. 2013. Effect of seaweed epibiotic bacterium Streptomyces violaceoruber
SCH-09 on marine fouling organisms. Fisheries Science 79(3):469–475
DOI 10.1007/s12562-013-0604-y.
Imhoff JF. 2016. Natural products from marine fungi—still an underrepresented resource.Marine
Drugs 14(1):19 DOI 10.3390/md14010019.
Iorhemen OT, Hamza RA, Tay JH. 2016.Membrane bioreactor (MBR) technology for wastewater
treatment and reclamation: membrane fouling. Membranes 6(2):33
DOI 10.3390/membranes6020033.
Jensen PR, Fenical W. 1996.Marine bacterial diversity as a resource for novel microbial products.
Journal of Industrial Microbiology & Biotechnology 17(5–6):346–351 DOI 10.1007/bf01574765.
Jiang P, Li J, Han F, Duan G, Lu X, Gu Y, YuW. 2011. Antibiofilm activity of an exopolysaccharide
from marine bacterium Vibrio sp. QY101. PLOS ONE 6(4):e18514
DOI 10.1371/journal.pone.0018514.
Joint I, Muhling M, Querellou Jl. 2010. Culturing marine bacteria—an essential prerequisite for
biodiscovery. Microbial Biotechnology 3(5):564–575 DOI 10.1111/j.1751-7915.2010.00188.x.
Kalinovskaya NI, Kuznetsova TA, Rashkes YV, Milgrom YM, Milgrom EG, Willis RH, Wood AI,
Kurtz HA, Carabedian C, Murphy P, Elyakov GB. 1995. Surfactin-like structures of five
cyclic depsipeptides from the marine isolate of Bacillus pumilus. Russian Chemical Bulletin
44(5):951–955 DOI 10.1007/bf00696935.
Kelecom A. 2002. Secondary metabolites from marine microorganisms. Anais da Academia
Brasileira de Cieˆncias 74(1):151–170 DOI 10.1590/s0001-37652002000100012.
Kjelleberg S, Steinberg P, Givskov M, Gram L, Manefield M, de Nys R. 1997. Do marine natural
products interfere with prokaryotic AHL regulatory systems? Aquatic Microbial Ecology
13:85–93 DOI 10.3354/ame013085.
Kupka J, Anke T, Giannetti BM, Steglich W. 1981. Antibiotics from basidiomycetes. Archives of
Microbiology 130:223–227.
Lade H, Paul D, Kweon JH. 2014. Quorum quenching mediated approaches for control of
membrane biofouling. International Journal of Biological Sciences 10(5):550–565
DOI 10.7150/ijbs.9028.
Laudien J, Wahl M. 2004. Associational resistance of fouled blue mussels (Mytilus edulis)
against starfish (Asterias rubens) predation: relative importance of structural and chemical
properties of the epibionts. Helgoland Marine Research 58(3):162–167
DOI 10.1007/s10152-004-0181-7.
Li Y, Xu Y, Fleischer CC, Huang J, Lin R, Yang L, Mao H. 2018. Impact of anti-biofouling surface
coatings on the properties of nanomaterials and their biomedical applications. Journal of
Materials Chemistry B 6(1):9–24 DOI 10.1039/c7tb01695f.
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 15/18
Maki JS, Rittschof D, Costlow JD, Mitchell R. 1988. Inhibition of attachment of larval barnacles,
Balanus amphitrite, by bacterial surface films. Marine Biology 97(2):199–206
DOI 10.1007/bf00391303.
Malve H. 2016. Exploring the ocean for new drug developments: Marine pharmacology. Journal of
Pharmacy and Bioallied Sciences 8(2):83–91 DOI 10.4103/0975-7406.171700.
Martins A, Vieira H, Gaspar H, Santos S. 2014. Marketed marine natural products in the
pharmaceutical and cosmeceutical industries: tips for success. Marine Drugs 12(2):1066–1101
DOI 10.3390/md12021066.
Matthews MA. 2000. Green Chemistry. Kirk-Othmer Encyclopedia of Chemical Technology.
Hoboken: John Wiley & Sons, Inc.
Mehbub FM, Lei J, Franco C, Zhang W. 2014. Marine sponge derived natural products
between 2001 and 2010: trends and opportunities for discovery of bioactives. Marine Drugs
12(8):4539–4577 DOI 10.3390/md12084539.
Mohamed NM, Rao V, Hamann MT, Kelly M, Hill RT. 2008.Monitoring bacterial diversity of the
marine sponge Ircinia strobilina upon transfer into aquaculture. Applied and Environmental
Microbiology 74(13):4133–4143 DOI 10.1128/aem.00454-08.
Mora C, Tittensor DP, Adl S, Simpson AGB, Worm B. 2011.How many species are there on earth
and in the ocean? PLOS Biology 9(8):e1001127 DOI 10.1371/journal.pbio.1001127.
Mourelle LM, Go´mez PC, Legido LJ. 2017. The potential use of marine microalgae and
cyanobacteria in cosmetics and thalassotherapy. Cosmetics 4(4):46
DOI 10.3390/cosmetics4040046.
Nunez-Pons L, Avila C. 2015. Natural products mediating ecological interactions in Antarctic
benthic communities: a mini-review of the known molecules. Natural Product Reports
32(7):1114–1130 DOI 10.1039/c4np00150h.
Nurioglu AG, Esteves AC, de With G. 2015. Non-toxic, non-biocide-release antifouling coatings
based on molecular structure design for marine applications. Journal of Materials Chemistry B
3(32):6547–6570 DOI 10.1039/c5tb00232j.
Omae I. 2003. Organotin antifouling paints and their alternatives. Applied Organometallic
Chemistry 17(2):81–105 DOI 10.1002/aoc.396.
Park MS, Kim YD, Kim BM, Kim YJ, Kim JK, Rhee JS. 2016. Effects of antifouling biocides on
molecular and biochemical defense system in the gill of the pacific oyster Crassostrea gigas.
PLOS ONE 11(12):e0168978 DOI 10.1371/journal.pone.0168978.
Penesyan A, Kjelleberg S, Egan S. 2010. Development of novel drugs from marine surface
associated microorganisms. Marine Drugs 8(3):438–459 DOI 10.3390/md8030438.
Pereira RC, Carvalho AGV, Gama BAP, Coutinho R. 2002. Field experimental evaluation of
secondary metabolites from marine invertebrates as antifoulants. Brazilian Journal of Biology
62(2):311–320 DOI 10.1590/s1519-69842002000200015.
Pimentel-Filho NdJ, Martins MCdF, Nogueira GB, Mantovani HC, Vanetti MC. 2014. Bovicin
HC5 and nisin reduce Staphylococcus aureus adhesion to polystyrene and change the
hydrophobicity profile and Gibbs free energy of adhesion. International Journal of Food
Microbiology 190:1–8 DOI 10.1016/j.ijfoodmicro.2014.08.004.
Prasad P, Aalbersberg W, Feussner KD, Van Wagoner RM. 2011. Papuamides E and F, cytotoxic
depsipeptides from the marine sponge Melophlus sp. Tetrahedron 67(44):8529–8531
DOI 10.1016/j.tet.2011.08.100.
Qian PY, Xu Y, Fusetani N. 2009.Natural products as antifouling compounds: recent progress and
future perspectives. Biofouling 26(2):223–234 DOI 10.1080/08927010903470815.
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 16/18
Rajasekar T, Balaji S, Kumaran S, Deivasigamani B, Pugzhavendhan SR. 2012. Isolation and
characterization of Marine fungal metabolites against clinical pathogens. Asian Pacific Journal of
Tropical Disease 2:S387–S392 DOI 10.1016/s2222-1808(12)60187-x.
Ram S, Mukul S, Penny J, Diwan SR. 2008. Clinical status of anti-cancer agents derived from
marine sources. Anti-Cancer Agents in Medicinal Chemistry 8(6):603–617
DOI 10.2174/1871520610808060603.
Re´dou V, Navarri M, Meslet-Cladie`re L, Barbier G, Burgaud G. 2015. Species richness and
adaptation of marine fungi from deep-subseafloor sediments. Applied and Environmental
Microbiology 81(10):3571–3583 DOI 10.1128/aem.04064-14.
Reich M, Labes A. 2017. How to boost marine fungal research: a first step towards a
multidisciplinary approach by combining molecular fungal ecology and natural products
chemistry. Marine Genomics 36:57–75 DOI 10.1016/j.margen.2017.09.007.
Rouhi AM. 1998. The squeeze on tributyltins. Chemical & Engineering News 76(17):41–42
DOI 10.1021/cen-v076n017.p041.
Salta M, Wharton JA, Dennington SP, Stoodley P, Stoke KR. 2013. Anti-biofilm performance of
three natural products against initial bacterial attachment. International Journal of Molecular
Sciences 14(11):21757–21780 DOI 10.3390/ijms141121757.
Samuel P, Prince L, Prabakaran P. 2011. Antibacterial activity of marine derived fungi collected
from South East Coast of Tamilnadu, India. Journal of Microbiology and Biotechnology Research
1(4):86–94.
Satheesh S, Ba-Akdah MA, Al-Sofyani AA. 2016. Natural antifouling compound production by
microbes associated with marine macroorganisms—a review. Electronic Journal of Biotechnology
21:26–35 DOI 10.1016/j.ejbt.2016.02.002.
Scopel M, Abraham WR, Antunes AL, Henriques AT, Macedo AJ. 2014. Mevalonolactone: an
inhibitor of staphylococcus epidermidis adherence and biofilm formation.Medicinal Chemistry
10(3):246–251 DOI 10.2174/15734064113096660055.
Shantanu B, Deep PR, Binata N, Monalisa P, Bharati M. 2013. Antimicrobial activity of two
diazotropic cyanobacteria against Staphylococcus aureus. ID—20133248222. International
Journal of Medicinal and Aromatic Plants 3:283–292.
Shao CL, Xu RF, Wang CY, Qian PY, Wang KL, Wei MY. 2015. Potent antifouling marine
dihydroquinolin-2(1H)-one-containing alkaloids from the gorgonian coral-derived fungus
Scopulariopsis sp. Marine Biotechnology 17(4):408–415 DOI 10.1007/s10126-015-9628-x.
Shao CL, Wu HX, Wang CY, Liu QA, Xu Y, Wei MY, Qian PY, Gu YC, Zheng CJ, She ZG, Lin YC.
2011. Potent antifouling resorcylic acid lactones from the gorgonian-derived fungus
Cochliobolus lunatus. Journal of Natural Products 74:629–633.
Silber J, Kramer A, Labes A, Tasdemir D. 2016. From discovery to production: biotechnology of
marine fungi for the production of new antibiotics. Marine Drugs 14(7):137
DOI 10.3390/md14070137.
Singh R, Parihar P, Singh M, Bajguz A, Kumar J, Singh S, Singh VP, Prasad SM. 2017.
Uncovering potential applications of cyanobacteria and algal metabolites in biology, agriculture
and medicine: current status and future prospects. Frontiers in Microbiology 8:515
DOI 10.3389/fmicb.2017.00515.
Stiefel P, Mauerhofer S, Schneider J, Maniura-Weber K, Rosenberg U, Ren Q. 2016. Enzymes
enhance biofilm removal efficiency of cleaners. Antimicrobial Agents and Chemotherapy
60(6):3647–3652 DOI 10.1128/aac.00400-16.
Swain SS, Padhy RN, Singh PK. 2015. Anticancer compounds from cyanobacterium Lyngbya
species: a review. Antonie van Leeuwenhoek 108(2):223–265 DOI 10.1007/s10482-015-0487-2.
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 17/18
Van SMMP, Bruggeman G, Van PJ. 1996. Exopolysaccharide degrading enzyme and use of the
same. Google Patents .
Van Houdt R, Michiels CW. 2010. Biofilm formation and the food industry, a focus on the
bacterial outer surface. Journal of Applied Microbiology 109(4):1117–1131
DOI 10.1111/j.1365-2672.2010.04756.x.
Vartoukian SR, Palmer RM, Wade WG. 2010. Strategies for culture of ‘unculturable’ bacteria.
FEMS Microbiology Letters 309:1–7 DOI 10.1111/j.1574-6968.2010.02000.x.
Vijayakumar S, Menakha M. 2015. Pharmaceutical applications of cyanobacteria—a review.
Journal of Acute Medicine 5(1):15–23 DOI 10.1016/j.jacme.2015.02.004.
Wahl M, Banaigs B. 1991. Marine epibiosis. III. Possible antifouling defense adaptations in
Polysyncraton lacazei (Giard) (Didemnidae, Ascidiacea). Journal of Experimental Marine Biology
and Ecology 145(1):49–63 DOI 10.1016/0022-0981(91)90005-h.
Wahl M, Goecke F, Labes A, Dobretsov S, Weinberger F. 2012. The second skin: ecological role of
epibiotic biofilms on marine organisms. Frontiers in Microbiology 3:292
DOI 10.3389/fmicb.2012.00292.
Wahl M, Jensen PR, Fenical W. 1994. Chemical control of bacterial epibiosis on ascidians.Marine
Ecology Progress Series 110:45–57 DOI 10.3354/meps110045.
Wang KL, Wu ZH, Wang Y, Hao YY, Wang Y. 2017. Mini-review: antifouling natural products
from marine microorganisms and their synthetic analogs. Marine Drugs 15(9):266
DOI 10.3390/md15090266.
Wilson MP, Schwarzman MR. 2009. Toward a new U.S. chemicals policy: rebuilding the
foundation to advance new science, green chemistry, and environmental health. Environmental
Health Perspectives 117(8):1202–1209 DOI 10.1289/ehp.0800404.
Winterton N. 2016. Green chemistry: deliverance or distraction? Clean Technologies and
Environmental Policy 18(4):991–1001 DOI 10.1007/s10098-016-1118-y.
Yang LH, Miao L, Lee OO, Li X, Xiong H, Pang KL, Vrijmoed L, Qian PY. 2007. Effect of culture
conditions on antifouling compound production of a sponge-associated fungus. Applied
Microbiology and Biotechnology 74(6):1221–1231 DOI 10.1007/s00253-006-0780-0.
Yebra DM, Kiil S, Dam-Johansen K. 2004. Antifouling technology—past, present and future steps
towards efficient and environmentally friendly antifouling coatings. Progress in Organic
Coatings 50(2):75–104 DOI 10.1016/j.porgcoat.2003.06.001.
Zhang L, An R,Wang J, Sun N, Zhang S, Hu J, Kuai J. 2005. Exploring novel bioactive compounds
from marine microbes. Current Opinion in Microbiology 8(3):276–281
DOI 10.1016/j.mib.2005.04.008.
Zhang T, Wang NF, Zhang YQ, Liu HY, Yu LY. 2015. Diversity and distribution of fungal
communities in the marine sediments of Kongsfjorden, Svalbard (High Arctic). Scientific
Reports 5(1):14524 DOI 10.1038/srep14524.
Zhang XY, Xu XY, Peng J, Ma CF, Nong XH, Bao J, Zhang GZ, Qi SH. 2014. Antifouling
potentials of eight deep-sea-derived fungi from the South China Sea. Journal of Industrial
Microbiology & Biotechnology 41(4):741–748 DOI 10.1007/s10295-014-1412-9.
Zimmerman RC, Alberte RS, Todd JS, Crews P. 1997. Phenolic acid sulfate esters for prevention
of marine biofouling. Google Patents .
Adnan et al. (2018), PeerJ, DOI 10.7717/peerj.5049 18/18
